CBX4_HUMAN - dbPTM
CBX4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CBX4_HUMAN
UniProt AC O00257
Protein Name E3 SUMO-protein ligase CBX4
Gene Name CBX4
Organism Homo sapiens (Human).
Sequence Length 560
Subcellular Localization Nucleus . Nucleus speckle . Localization to nuclear polycomb bodies is required for ZNF131 sumoylation (PubMed:22467880). Localized in distinct foci on chromatin (PubMed:18927235).
Protein Description E3 SUMO-protein ligase which facilitates SUMO1 conjugation by UBE2I. [PubMed: 12679040 Involved in the sumoylation of HNRNPK, a p53/TP53 transcriptional coactivator, hence indirectly regulates p53/TP53 transcriptional activation resulting in p21/CDKN1A expression. Monosumoylates ZNF131]
Protein Sequence MELPAVGEHVFAVESIEKKRIRKGRVEYLVKWRGWSPKYNTWEPEENILDPRLLIAFQNRERQEQLMGYRKRGPKPKPLVVQVPTFARRSNVLTGLQDSSTDNRAKLDLGAQGKGQGHQYELNSKKHHQYQPHSKERAGKPPPPGKSGKYYYQLNSKKHHPYQPDPKMYDLQYQGGHKEAPSPTCPDLGAKSHPPDKWAQGAGAKGYLGAVKPLAGAAGAPGKGSEKGPPNGMMPAPKEAVTGNGIGGKMKIVKNKNKNGRIVIVMSKYMENGMQAVKIKSGEVAEGEARSPSHKKRAADERHPPADRTFKKAAGAEEKKVEAPPKRREEEVSGVSDPQPQDAGSRKLSPTKEAFGEQPLQLTTKPDLLAWDPARNTHPPSHHPHPHPHHHHHHHHHHHHAVGLNLSHVRKRCLSETHGEREPCKKRLTARSISTPTCLGGSPAAERPADLPPAAALPQPEVILLDSDLDEPIDLRCVKTRSEAGEPPSSLQVKPETPASAAVAVAAAAAPTTTAEKPPAEAQDEPAESLSEFKPFFGNIIITDVTANCLTVTFKEYVTV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
28PhosphorylationIRKGRVEYLVKWRGW
CCCCCCEEEEEECCC
17.59-
36PhosphorylationLVKWRGWSPKYNTWE
EEEECCCCCCCCCCC
17.8424719451
38UbiquitinationKWRGWSPKYNTWEPE
EECCCCCCCCCCCCH
45.69-
77SumoylationRKRGPKPKPLVVQVP
HHCCCCCCCEEEECC
58.0528112733
90PhosphorylationVPTFARRSNVLTGLQ
CCCCCHHCCCCCCCC
26.2428985074
94PhosphorylationARRSNVLTGLQDSST
CHHCCCCCCCCCCCC
31.4029978859
99PhosphorylationVLTGLQDSSTDNRAK
CCCCCCCCCCCCCEE
23.3729978859
100PhosphorylationLTGLQDSSTDNRAKL
CCCCCCCCCCCCEEE
48.3329978859
101PhosphorylationTGLQDSSTDNRAKLD
CCCCCCCCCCCEEEE
41.0429978859
106SumoylationSSTDNRAKLDLGAQG
CCCCCCEEEECCCCC
39.0228112733
106AcetylationSSTDNRAKLDLGAQG
CCCCCCEEEECCCCC
39.0225953088
106UbiquitinationSSTDNRAKLDLGAQG
CCCCCCEEEECCCCC
39.02-
106SumoylationSSTDNRAKLDLGAQG
CCCCCCEEEECCCCC
39.02-
114SumoylationLDLGAQGKGQGHQYE
EECCCCCCCCCCEEE
35.6628112733
114SumoylationLDLGAQGKGQGHQYE
EECCCCCCCCCCEEE
35.66-
114UbiquitinationLDLGAQGKGQGHQYE
EECCCCCCCCCCEEE
35.66-
120PhosphorylationGKGQGHQYELNSKKH
CCCCCCEEECCCCCC
19.4027642862
125UbiquitinationHQYELNSKKHHQYQP
CEEECCCCCCCCCCC
55.86-
125AcetylationHQYELNSKKHHQYQP
CEEECCCCCCCCCCC
55.8625953088
125SumoylationHQYELNSKKHHQYQP
CEEECCCCCCCCCCC
55.8628112733
137MethylationYQPHSKERAGKPPPP
CCCCCCCCCCCCCCC
52.99-
147PhosphorylationKPPPPGKSGKYYYQL
CCCCCCCCCCEEEEE
46.5725072903
149UbiquitinationPPPGKSGKYYYQLNS
CCCCCCCCEEEEECC
36.8519608861
149AcetylationPPPGKSGKYYYQLNS
CCCCCCCCEEEEECC
36.8519608861
149SumoylationPPPGKSGKYYYQLNS
CCCCCCCCEEEEECC
36.85-
149SumoylationPPPGKSGKYYYQLNS
CCCCCCCCEEEEECC
36.8528112733
150PhosphorylationPPGKSGKYYYQLNSK
CCCCCCCEEEEECCC
15.7825072903
151PhosphorylationPGKSGKYYYQLNSKK
CCCCCCEEEEECCCC
6.5525072903
152PhosphorylationGKSGKYYYQLNSKKH
CCCCCEEEEECCCCC
11.9325072903
157AcetylationYYYQLNSKKHHPYQP
EEEEECCCCCCCCCC
55.8625953088
157SumoylationYYYQLNSKKHHPYQP
EEEEECCCCCCCCCC
55.8628112733
158UbiquitinationYYQLNSKKHHPYQPD
EEEECCCCCCCCCCC
47.14-
167SumoylationHPYQPDPKMYDLQYQ
CCCCCCCCCCCCCCC
58.4328112733
167UbiquitinationHPYQPDPKMYDLQYQ
CCCCCCCCCCCCCCC
58.43-
169PhosphorylationYQPDPKMYDLQYQGG
CCCCCCCCCCCCCCC
21.4526552605
173PhosphorylationPKMYDLQYQGGHKEA
CCCCCCCCCCCCCCC
19.2029214152
178UbiquitinationLQYQGGHKEAPSPTC
CCCCCCCCCCCCCCC
59.87-
178SumoylationLQYQGGHKEAPSPTC
CCCCCCCCCCCCCCC
59.8728112733
182PhosphorylationGGHKEAPSPTCPDLG
CCCCCCCCCCCCCCC
39.6330266825
184PhosphorylationHKEAPSPTCPDLGAK
CCCCCCCCCCCCCCC
40.7930266825
191SumoylationTCPDLGAKSHPPDKW
CCCCCCCCCCCCCHH
47.7228112733
197AcetylationAKSHPPDKWAQGAGA
CCCCCCCHHHCCCCC
50.6425953088
197UbiquitinationAKSHPPDKWAQGAGA
CCCCCCCHHHCCCCC
50.64-
205SumoylationWAQGAGAKGYLGAVK
HHCCCCCCCCHHCHH
47.36-
205UbiquitinationWAQGAGAKGYLGAVK
HHCCCCCCCCHHCHH
47.36-
205SumoylationWAQGAGAKGYLGAVK
HHCCCCCCCCHHCHH
47.3628112733
207PhosphorylationQGAGAKGYLGAVKPL
CCCCCCCCHHCHHCC
10.9718083107
212UbiquitinationKGYLGAVKPLAGAAG
CCCHHCHHCCCCCCC
33.51-
212AcetylationKGYLGAVKPLAGAAG
CCCHHCHHCCCCCCC
33.5125953088
212SumoylationKGYLGAVKPLAGAAG
CCCHHCHHCCCCCCC
33.51-
212SumoylationKGYLGAVKPLAGAAG
CCCHHCHHCCCCCCC
33.5128112733
223SumoylationGAAGAPGKGSEKGPP
CCCCCCCCCCCCCCC
59.2028112733
223SumoylationGAAGAPGKGSEKGPP
CCCCCCCCCCCCCCC
59.20-
223UbiquitinationGAAGAPGKGSEKGPP
CCCCCCCCCCCCCCC
59.20-
249SumoylationTGNGIGGKMKIVKNK
CCCCCCCCEEEEECC
31.6328112733
249SumoylationTGNGIGGKMKIVKNK
CCCCCCCCEEEEECC
31.63-
249UbiquitinationTGNGIGGKMKIVKNK
CCCCCCCCEEEEECC
31.63-
249MethylationTGNGIGGKMKIVKNK
CCCCCCCCEEEEECC
31.63-
249AcetylationTGNGIGGKMKIVKNK
CCCCCCCCEEEEECC
31.6325953088
267PhosphorylationGRIVIVMSKYMENGM
CCEEEEECHHHHCCE
15.1120068231
268SumoylationRIVIVMSKYMENGMQ
CEEEEECHHHHCCEE
30.4428112733
269PhosphorylationIVIVMSKYMENGMQA
EEEEECHHHHCCEEE
11.4520068231
278UbiquitinationENGMQAVKIKSGEVA
HCCEEEEEEECCCCC
47.64-
278SumoylationENGMQAVKIKSGEVA
HCCEEEEEEECCCCC
47.64-
278SumoylationENGMQAVKIKSGEVA
HCCEEEEEEECCCCC
47.6428112733
280UbiquitinationGMQAVKIKSGEVAEG
CEEEEEEECCCCCCC
46.84-
280SumoylationGMQAVKIKSGEVAEG
CEEEEEEECCCCCCC
46.8428112733
280SumoylationGMQAVKIKSGEVAEG
CEEEEEEECCCCCCC
46.84-
281PhosphorylationMQAVKIKSGEVAEGE
EEEEEEECCCCCCCC
43.5929396449
291PhosphorylationVAEGEARSPSHKKRA
CCCCCCCCHHHHHHH
37.4923401153
293PhosphorylationEGEARSPSHKKRAAD
CCCCCCHHHHHHHHH
49.5421955146
320SumoylationAAGAEEKKVEAPPKR
HCCCHHHCCCCCCCC
48.8928112733
333PhosphorylationKRREEEVSGVSDPQP
CCCHHHHCCCCCCCC
36.4426074081
336PhosphorylationEEEVSGVSDPQPQDA
HHHHCCCCCCCCCCC
47.2820044836
345PhosphorylationPQPQDAGSRKLSPTK
CCCCCCCCCCCCCCH
28.1428985074
349PhosphorylationDAGSRKLSPTKEAFG
CCCCCCCCCCHHHHC
33.2923927012
351PhosphorylationGSRKLSPTKEAFGEQ
CCCCCCCCHHHHCCC
37.8323927012
352SumoylationSRKLSPTKEAFGEQP
CCCCCCCHHHHCCCC
50.8928112733
363PhosphorylationGEQPLQLTTKPDLLA
CCCCCCCCCCCCCEE
21.5823927012
364PhosphorylationEQPLQLTTKPDLLAW
CCCCCCCCCCCCEEC
49.5323927012
365SumoylationQPLQLTTKPDLLAWD
CCCCCCCCCCCEECC
31.1628112733
365 (in isoform 1)Ubiquitination-31.1621906983
365SumoylationQPLQLTTKPDLLAWD
CCCCCCCCCCCEECC
31.16-
365UbiquitinationQPLQLTTKPDLLAWD
CCCCCCCCCCCEECC
31.162190698
415PhosphorylationHVRKRCLSETHGERE
HHHHHHHHHCCCCCC
44.0429255136
417PhosphorylationRKRCLSETHGEREPC
HHHHHHHCCCCCCCC
31.6319276368
429PhosphorylationEPCKKRLTARSISTP
CCCHHHHCCCCCCCC
24.8626074081
432PhosphorylationKKRLTARSISTPTCL
HHHHCCCCCCCCCCC
20.5829255136
434PhosphorylationRLTARSISTPTCLGG
HHCCCCCCCCCCCCC
29.5829255136
435PhosphorylationLTARSISTPTCLGGS
HCCCCCCCCCCCCCC
22.4323663014
437PhosphorylationARSISTPTCLGGSPA
CCCCCCCCCCCCCCC
22.0529255136
442PhosphorylationTPTCLGGSPAAERPA
CCCCCCCCCCCCCCC
15.0128387310
467PhosphorylationPEVILLDSDLDEPID
CCEEEECCCCCCCEE
39.7927499020
480PhosphorylationIDLRCVKTRSEAGEP
EEEEEEECCCCCCCC
21.0126074081
482PhosphorylationLRCVKTRSEAGEPPS
EEEEECCCCCCCCCC
36.7126074081
494SumoylationPPSSLQVKPETPASA
CCCCCCCCCCCCHHH
24.95-
494SumoylationPPSSLQVKPETPASA
CCCCCCCCCCCCHHH
24.9515592428
495PhosphorylationPSSLQVKPETPASAA
CCCCCCCCCCCHHHH
52.4117018294
497PhosphorylationSLQVKPETPASAAVA
CCCCCCCCCHHHHHH
32.4528112733

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
495TPhosphorylationKinaseHIPK2Q9H2X6
PhosphoELM
497TPhosphorylationKinaseHIPK2Q9H2X6
Uniprot
497TPhosphorylationKinaseP38AQ16539
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
494KPhosphorylation

15592428
494KSumoylation

15592428
497TPhosphorylation

17018294

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CBX4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
KMT2A_HUMANKMT2Aphysical
12829790
CTBP1_HUMANCTBP1physical
12829790
BMI1_HUMANBMI1physical
12829790
CTBP1_HUMANCTBP1physical
12679040
RING1_HUMANRING1physical
9199346
BMI1_HUMANBMI1physical
9199346
PHC1_HUMANPHC1physical
9199346
RB_HUMANRB1genetic
11583618
CTBP1_HUMANCTBP1physical
9858600
CTBP2_HUMANCTBP2physical
9858600
KDM5B_HUMANKDM5Bphysical
19336002
SUV91_HUMANSUV39H1physical
12101246
DNM3A_HUMANDNMT3Aphysical
17439403
H31T_HUMANHIST3H3physical
12700765
SYUA_HUMANSNCAphysical
21256122
RING2_HUMANRNF2physical
22325352
PCGF2_HUMANPCGF2physical
22325352
BMI1_HUMANBMI1physical
22325352
RING1_HUMANRING1physical
22325352
PHC1_HUMANPHC1physical
22325352
PHC2_HUMANPHC2physical
22325352
PHC3_HUMANPHC3physical
22325352
CBX8_HUMANCBX8physical
22325352
SCMH1_HUMANSCMH1physical
22325352
MGAP_HUMANMGAphysical
22325352
ZEB2_HUMANZEB2physical
16061479
HNRPK_HUMANHNRNPKphysical
22825850
ZN131_HUMANZNF131physical
22467880
ANR26_HUMANANKRD26physical
21282530
BMI1_HUMANBMI1physical
21282530
CBX2_HUMANCBX2physical
21282530
CENPE_HUMANCENPEphysical
21282530
CSK21_HUMANCSNK2A1physical
21282530
CSK22_HUMANCSNK2A2physical
21282530
CSK2B_HUMANCSNK2Bphysical
21282530
DI3L2_HUMANDIS3L2physical
21282530
GTF2I_HUMANGTF2Iphysical
21282530
H2B1B_HUMANHIST1H2BBphysical
21282530
1433B_HUMANYWHABphysical
21282530
DCAF6_HUMANDCAF6physical
21282530
KDM3A_HUMANKDM3Aphysical
21282530
TRNK1_HUMANTRANK1physical
21282530
MYCB2_HUMANMYCBP2physical
21282530
NPM_HUMANNPM1physical
21282530
PAR12_HUMANPARP12physical
21282530
PARP1_HUMANPARP1physical
21282530
PHC2_HUMANPHC2physical
21282530
PSME3_HUMANPSME3physical
21282530
RING2_HUMANRNF2physical
21282530
RN213_HUMANRNF213physical
21282530
CD158_HUMANCCDC158physical
21282530
ZKSC7_HUMANZKSCAN7physical
21282530
CBX4_HUMANCBX4physical
21282530
1433E_HUMANYWHAEphysical
21282530
1433Z_HUMANYWHAZphysical
21282530
BMI1_HUMANBMI1physical
26496610
PHC1_HUMANPHC1physical
26496610
PHC2_HUMANPHC2physical
26496610
H33_HUMANH3F3Aphysical
26496610
HELLS_HUMANHELLSphysical
26496610
MYL6_HUMANMYL6physical
26496610
RAD51_HUMANRAD51physical
26496610
RING1_HUMANRING1physical
26496610
RING2_HUMANRNF2physical
26496610
SDC2_HUMANSDC2physical
26496610
TXTP_HUMANSLC25A1physical
26496610
TTC1_HUMANTTC1physical
26496610
1433T_HUMANYWHAQphysical
26496610
KDM2A_HUMANKDM2Aphysical
26496610
S18L2_HUMANSS18L2physical
26496610
TMA16_HUMANTMA16physical
26496610
IMPCT_HUMANIMPACTphysical
26496610
CBX8_HUMANCBX8physical
26496610
WIZ_HUMANWIZphysical
26496610
PHC3_HUMANPHC3physical
26496610
USMG5_HUMANUSMG5physical
26496610
RM55_HUMANMRPL55physical
26496610
LAMA1_HUMANLAMA1physical
26496610

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CBX4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-149, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND MASSSPECTROMETRY.
Sumoylation
ReferencePubMed
"Multiple activities contribute to Pc2 E3 function.";
Kagey M.H., Melhuish T.A., Powers S.E., Wotton D.;
EMBO J. 24:108-119(2005).
Cited for: SUMOYLATION AT LYS-494.

TOP